<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Patients with end-stage <z:hpo ids='HP_0000726'>dementia</z:hpo> typically are very immobilized </plain></SENT>
<SENT sid="1" pm="?"><plain>Could this state actually be a form of lorazepam-responsive catatonia </plain></SENT>
<SENT sid="2" pm="."><plain>Catatonia has been documented following <z:hpo ids='HP_0001297'>cerebrovascular accidents</z:hpo>, head injury, HIV <z:hpo ids='HP_0002383'>encephalitis</z:hpo>, <z:mp ids='MP_0009277'>brain tumors</z:mp>, and multiple <z:mp ids='MP_0000612'>sclerosis</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>Identified anatomical substrates include frontal lobes, parietal lobes, limbic system, diencephalon, and basal ganglia </plain></SENT>
<SENT sid="4" pm="."><plain>Given that <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e>, vascular <z:hpo ids='HP_0000726'>dementia</z:hpo>, Lewy body <z:hpo ids='HP_0000726'>dementia</z:hpo>, <z:e sem="disease" ids="C0393570" disease_type="Disease or Syndrome" abbrv="">corticobasal degeneration</z:e>, <z:hpo ids='HP_0002145'>frontotemporal dementia</z:hpo>, and Parkinsonian <z:hpo ids='HP_0000726'>dementia</z:hpo> often have degeneration in some of the same areas, dramatic awakenings might be possible by giving lorazepam challenges to locked-in <z:hpo ids='HP_0000726'>dementia</z:hpo> patients </plain></SENT>
<SENT sid="5" pm="."><plain>If even a small percentage were lorazepam responders, the impact worldwide would be tremendous </plain></SENT>
<SENT sid="6" pm="."><plain>Serious consideration should be given to undertaking large-scale clinical trials </plain></SENT>
</text></document>